• Home
  • NEW DAY MEDICINE
  • 8 (82) 2025
  • 64 -8 (82) 2025 - Idiev G.E., Babayeva N.M. - MODERN APPROACHES TO THE TREATMENT, PREVENTION, AND REHABILITATION OF PATIENTS WITH ORAL MUCOSAL LEUKOPLAKIA

64 -8 (82) 2025 - Idiev G.E., Babayeva N.M. - MODERN APPROACHES TO THE TREATMENT, PREVENTION, AND REHABILITATION OF PATIENTS WITH ORAL MUCOSAL LEUKOPLAKIA

MODERN APPROACHES TO THE TREATMENT, PREVENTION, AND REHABILITATION OF PATIENTS WITH ORAL MUCOSAL LEUKOPLAKIA

Idiev G.E. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Babayeva N.M. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Oral mucosal leukoplakia is a chronic condition with a high risk of malignant transformation. This article presents epidemiological data, risk factors, pathogenetic mechanisms, and current approaches to treatment, prevention, and rehabilitation of patients. Emphasis is placed on the need for a comprehensive strategy, including elimination of etiological factors, use of pharmacological, surgical, and physiotherapeutic methods, as well as regular follow-up to prevent recurrences and ensure early detection of malignancy.

Keywords: leukoplakia, oral mucosa, treatment, prevention, rehabilitation, malignant transformation.

First page

361

Last page

364

For citation:Idiev G.E., Babayeva N.M. - MODERN APPROACHES TO THE TREATMENT, PREVENTION, AND REHABILITATION OF PATIENTS WITH ORAL MUCOSAL LEUKOPLAKIA//New Day in Medicine 8(82)2025 361-364 https://newdayworldmedicine.com/en/new_day_medicine/8-82-2025

List of References

  1. World Health Organization. Oral Health Surveys: Basic Methods. WHO, 2013.
  2. Warnakulasuriya S. et al. Oral potentially malignant disorders: a consensus report. Oral Diseases, 2021;27(3): 736–752.
  3. Gupta N. et al. Global epidemiology of oral leukoplakia. Oral Oncology, 2016;62: 70–81.
  4. Хакимов Ф.Ш., Абдуллаев Р.К. Эпидемиология и клинические особенности лейкоплакии слизистой оболочки полости рта в Узбекистане. Стоматология, 2020;99(2): 45–49.
  5. Petti S. Lifestyle risk factors for oral cancer. Oral Oncology, 2009;45(4-5): 340–350.
  6. Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol, 2005;32: S59–S66.
  7. Kumar A. et al. Role of oxidative stress in oral diseases. J Oral Maxillofac Pathol, 2013;17(1): 6–15.
  8. Napier S.S., Speight P.M. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med, 2008;37(1): 1–10.
  9. Zhang Z., et al. Genetic polymorphisms and susceptibility to oral leukoplakia. Cancer Epidemiol Biomarkers Prev, 2010;19(8): 2061–2067.
  10. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncology, 2009;45(4-5): 317–323.
  11. Warnakulasuriya S., Johnson N.W., van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med, 2007;36(10): 575–580.
  12. Arduino P.G. et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients. Med Oral Patol Oral Cir Bucal, 2009;14(9): E461–E466.
  13. Lodi G., Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med, 2008;37(2): 63–69.
  14. Silverman S. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer, 1984;53(3): 563–568.
  15. Lodi G., Porter S.R. Strategies for the management of oral potentially malignant disorders and oral cancer prevention. Curr Oral Health Rep, 2016;3(1): 1–7.

    file

    download